Welcome to the Podiatry Arena forums

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members, upload content, view attachments, receive a weekly email update of new discussions, access other special features. Registered users do not get displayed the advertisements in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

  1. Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
    Dismiss Notice
Dismiss Notice
Have you considered the Clinical Biomechanics Boot Camp Online, for taking it to the next level? See here for more.
Dismiss Notice
Have you liked us on Facebook to get our updates? Please do. Click here for our Facebook page.
Dismiss Notice
Do you get the weekly newsletter that Podiatry Arena sends out to update everybody? If not, click here to organise this.

Greater prevention should be our focus

Discussion in 'Diabetic Foot & Wound Management' started by Boots n all, Jun 8, 2015.

  1. Boots n all

    Boots n all Well-Known Member


    Members do not see these Ads. Sign Up.
    Came across this and thought l would share. l couldn't agree more.

    http://exceed-magazine.com/news/dia...nning-debate-against-wound-care-says-alg-ceo/

    The CEO of a leading medical technology company has called for greater emphasis to be placed on the prevention of diabetic foot ulcers rather than wound care.

    Hugh Sheridan, CEO of ALG, was speaking after attending the 7th International Symposium on the Diabetic Foot in The Hague.

    Sheridan said: “For years, the wound care industry has dominated the subject of diabetic foot, but the feedback I received at the conference was that there was a desire for the agenda to move more towards preventative action.

    “ALG believes passionately that we should be considering the 380 million people affected by diabetes worldwide rather than the 12 per cent who have a foot ulcer.

    “For too long, the provision of consumable wound dressings has dominated the market as opposed to prevention methods which can drastically reduce the risk of ulcers occurring.”

    Michelle Weddell, Head of Education for ALG, gave a talk entitled “We don’t believe in ulcers”, stressing the importance of pre-ulcer offloading using foot orthotics.

    Plantar Callus, a risk factor for ulceration, indicates abnormal foot pressures and occurs most frequently under the metatarsal heads.

    Michelle explained that NICE guidelines in the UK for Type 2 Diabetes foot problems, prevention and management highlighted the benefits of specially designed insoles as inserts to patients’ shoes or in combination with specially designed shoes to reduce abnormal foot pressures and foot ulcers.

    Michelle said: “Diabetes affects more than 380 million people worldwide and by 2030 this figure will have risen to 550 million – 10 per cent of the world’s adult population.

    “In certain parts of the world there is no national guidance on diabetic foot and no real prevention. The focus instead is on wound care, but with the right podiatry care upon diagnosis of diabetes, these ulcers would not have been allowed to develop. This would lead to significant long-term healthcare savings.

    “At The Hague and also recently in the Middle East, I spoke about the importance of offloading and biomechanics. Proper offloading is critical to the prevention of diabetic foot ulcers.”

    The 7th International Symposium on the Diabetic Foot – held once every four years – brought together more than 1,500 delegates from over 100 countries.

    Diaped, the global diabetic foot care brand owned by ALG, showcased a number of key products including:

    Diaped Duosoft Flow insoles designed for patients with diabetes and other conditions which result in sensitive feet;
    Solesee – an easy-to-use mirror for people with high risk feet conditions;
    Non-contact digital thermometer – an early warning tool in the fight against neuropathic ulceration;
    Diaped Flux-200 – pocket-size Doppler to detect and evaluate blood flow for vascular assessment in diabetic foot.

    Diaped’s sister brand, Aortha, a specialist in orthotics and prosthetics, exhibited its pioneering 3D insole technology, due to be launched in early 2016.

    The technology, which can print a pair of insoles in an hour, has already attracted significant interest in the UK and North America.

    The breakthrough will allow custom-made and more supportive insoles to be created six times faster than anything else on the market.

    Sheridan said: “The 3D printing market is moving quickly and the tremendous feedback we have had from customers demonstrates that we are creating something significant.

    “Aortha OrthaPrint and Aortha OrthaFlex will provide orthotists and podiatrists with the ability to print a pair of insoles in an hour.

    “The technology transforms the speed with which custom-made, multi-density insoles can be produced.

    “This advance fits with the ALG mission to develop and bring to market life-changing products that not only change the way people move, but also the way they feel.”

    ALG distributes its products to more than 70 countries through its offices in the UK, Australia, United States and United Arab Emirates. It is continually investing in the research and development of existing and new products in O&P, podiatry and physiotherapy through its experienced team of medical professionals and clinicians
     
  2. Dr. Steven King

    Dr. Steven King Well-Known Member

    Sheridan said: “For years, the wound care industry has dominated the subject of diabetic foot, but the feedback I received at the conference was that there was a desire for the agenda to move more towards preventative action.

    Would these CEO's be willing to listen to a few of us foot doctors that are doing just that?

    My experience says no.

    "If it is not what we are used to then it is no use to us" is their common blow off response.

    We can and should do more than foam!

    Mahalo,
    Dr. Steven King

    Developer of a metatarsal head off-weighting orthotic device US Pat #8,353,968
    Co-Principle Investigator SBIR A11-109 "Advanced Composite Orthotics for the Reduction of Stress Fractures." US Department of Defense and Army Medical Research and Materials Command.
     
  3. Lab Guy

    Lab Guy Well-Known Member

    380 million diabetics. I wonder how many people would have type two diabetes if they had a low carb diet from an early age. Many patients do not want to give up their sugar and when patients do not want to help themselves, we will always be fighting an uphill battle.

    Steven
     
  4. Boots n all

    Boots n all Well-Known Member

    Hi Steve, hospitals spend big on wound healing and rehab, but are spending little on prevention is the point l think he was trying to make? The client is not even on the hospitals radar until the foot breaks down in some way.

    Recently l quoted for custom made orthoses and custom boots for diabetic charcot deformed foot, price $1,875.

    The response from the Hospitals head of the Diabetic Foot Unit, "That's great, it costs me $1500 a day if they break down and need hospitalization, not to mention the cost to my budget as they become an outpatient, lets get started."

    He didnt give an end figure of out patient cost, other than staff cost are $135 an hour plus materials, so the Pedorthic devices at $1875 are a bargain.

    Sadly most hospitals budgets are focused on the wound aspect of the diabetic foot so little funding remains for prevention of further break down. Crazy when you think of the saving that are there to be had and the stress that could be avoided for the client if prevention was the focus.
     
Loading...

Share This Page